BMY R&D Expenses
Bristol Myers Squibb · R&D Expenses
BMY R&D Expenses
Latest reported$10.72Bperiod ending
BMY R&D Expenses ($0.00 → $10.72B)
Annual R&D Expenses
High-resolution chart · PNG
BMY r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 9,951,000,000 | |
| 11,159,000,000 | |
| 9,299,000,000 | |
| 9,509,000,000 | |
| 10,195,000,000 | |
| 11,143,000,000 | |
| 6,148,000,000 | |
| 6,332,000,000 | |
| 6,468,000,000 | |
| 5,012,000,000 | |
| 5,920,000,000 | |
| 4,534,000,000 | |
| 3,731,000,000 | |
| 3,904,000,000 | |
| 3,839,000,000 | |
| 3,566,000,000 | |
| 3,647,000,000 | |
| 3,512,000,000 | |
| 3,282,000,000 | |
| 2,991,000,000 | |
| 2,678,000,000 | |
| 2,500,000,000 | |
| 2,279,000,000 | |
| 2,206,000,000 | |
| 2,183,000,000 | |
| 1,939,000,000 | |
| 1,759,000,000 | |
| 1,506,000,000 | |
| 1,385,000,000 | |
| 1,276,000,000 | |
| 1,199,000,000 | |
| 1,108,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |